^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    CHZ868

    i
    Other names: CHZ868, NVP-CHZ868, CHZ 868, NVP CHZ868, CHZ-868, NVPCHZ868
    Company:
    Memorial Sloan-Kettering Cancer Center, Novartis
    Drug class:
    JAK2 inhibitor
    Related drugs: